In clinical trials of patients with various types of retinal diseases, including macular degeneration, diabetic retinopathy, retinitis pigmentosa, and hemorrhagic and hypertensive retinopathy, all persons given Flavay® showed significant improvement.
A Completely Safe, Non-Drug, Natural Relief of Retinopathies
Flavay® has been sold world-wide for vascular and eye health and extensively tested in humans for more than 50 years. The vascular protective activity of Flavay® has been established by many significant studies, demonstrating several important ways in which Flavay® may protect the vascular health of the eyes. Flavay® can protect the eyes from free radical damage, support overall circulatory function, reinforce collagen structures of the retina, enhance the eyes ability to visually adapt to different light environments, and protect the health of the eye and retina.
Protecting the Smallest Blood Vessels in the Eyes
—Ms. S. G.
The health of the eyes depends to a great extent on the integrity of the fine vessels that supply blood to the area. Research shows that Flavay® has the capacity to improve visual performance in various ways.
Flavay® actually strengthens collagen in vascular walls and capillaries (the smallest vessels), making the vessels stronger and more elastic. Flavay® alters the membrane receptor conformation of vascular walls, reducing the damaging effects of the destructive enzymes elastase, collagenase and hyaluronidase, by preventing them from attaching to and degrading vascular walls. Flavay® further prevents destruction of vascular walls by preventing the attachment to membranes of histamine and hyaluronidase, both of which can decrease the strength of vessel walls. Thus, in addition to preventing the root causes of vessel occlusion, Flavay® strengthens vessels, thereby reducing the risk of a rupture or hemorrhage, and helping to prevent and relieve vascular fragility.
In clinical trials of patients with various types of retinal diseases, including macular degeneration, diabetic retinopathy, retinitis pigmentosa, and hemorrhagic and hypertensive retinopathy, all persons given Flavay® showed significant improvement following therapy. Flavay® has been shown to reduce pressure in ophthalmic membranes by preventing abnormal leakage of fluids into the orbital cavity and tissues.
—retired medical doctor
Retinopathy is especially a problem for diabetics, who suffer from greatly increased capillary permeability in their eyes. The vascular wall and eye lens of a diabetic are especially aggravated due to the nature of the disease.
There are basically two types of diabetic retinopathy, the background type and the proliferative type. The background type is characterized by microaneurisms (small sacs which develop as a result of excessive vascular dilation), intraretinal hemorrhages, yellowish waxy exudates, and swelling of the macula. The proliferative type is characterized by the development of new vessels in the retina and disk, proliferation of fibrous tissue, vitreous hemorrhage and detachment of the retina. In either case, diabetic retinopathy is one of the leading causes of blindness, and any agent that can help to stem the effects of retinopathy is of value.
Many clinical studies conducted in Europe show that Flavay® greatly improved symptoms in patients with diabetic retinopathies and maculopathies. In one study of 26 diabetic ophthalmic patients, 100 to 200 mg per day of Flavay® proved of therapeutic value in controlling vascular incidents, which are characteristic of diabetic retinopathy. Several weeks of treatment resulted in noteworthy improvement in vascular incidents, with reduced microaneurisms and diminished exudations, and overall improvement in capillary fragility. The vision of those taking Flavay® not only stopped decreasing, but even improved. Flavay® protected cells against free radical damage, and it sealed the microbleedings in the retina that obscure vision.
Clinical studies have conclusively demonstrated Flavay's® ability to stabilize microcapillaries in the retinal membranes and it has therefore been licensed in France for treating diabetic retinopathy. This shows that Flavay® should be part of the daily nutritional regimen of every diabetic person.
Improving Visual Performance in the Dark After Glare
Double-blind studies have demonstrated that Flavay® may significantly improve visual performance in the dark after glare. In one study of 100 workers who sit in front of computer monitors or drive for a living, the administration of 200mg per day of Flavay® enhanced visual adaptation from bright light. This is the ability of the eyes to see well in a low-light situation after being adjusted to bright light. In the eyes, a substance known as rhodopsin, or visual purple, affects visual acuity in low light. Rhodopsin is made by vitamin A and Flavay appears to enhance the speed of rhodopsin activity, making it easier to go from high to low light. Thus, just as Flavay® enhances the activity of vitamin C in the body, it enhances an important function of vitamin A.
Patented “Radical Scavenger” Effect of Flavay®
"[A] method for preventing and fighting the harmful biological effects of free radicals in the organism of warm blooded animals and more especially human beings, namely cerebral involution, hypoxia following atherosclerosis, cardiac or cerebral infarction, tumour promotion, inflammation, ischaemia, alterations of the synovial liquid, collagen degradation, among others. The method consists in administering to said animals and especially to human beings an amount, efficient against said effects, of a plant extract with a proanthocyanidins content which has a radical scavenger effect" U.S. Patent No. 4,698,360 (1987).
The powerful free radical scavenging protection of Flavay® is especially beneficial to the eyes, with its delicate microcapillaries.
Free Radicals, Cataracts and Macular Degeneration
In the presence of oxygen, ultraviolet light generates free radicals or precursors, and oxidative damage to lens proteins leads to increasing opacity. In the young, repair mechanisms exist, but as we age they become progressively less effective. It has been hypothesized, through both animal and human studies, that oxidation is involved in all types of cataracts and of age-related macular degeneration. A number of epidemiologic studies have found that age-related eye diseases consumed significantly less antioxidants, particularly vitamin C, than did persons who did not develop those eye conditions. Research shows that Flavay® dramatically extends the lifetime of vitamin C in the body, Flavay® provides its own powerful antioxidant protection to the eyes and its tiny blood vessels, and Flavay® enhances the protective effect of alpha-tocopherol (vitamin E) in the eye and retina.
Best Protection for the Health of Your Eyes and Retinas
Flavay® is the actual product that has been licensed and sold in France for protection against diabetic retinopathy. As shown above, Flavay® can protect the eyes from free radical damage, support overall circulatory function, reinforce collagen structures of the retina, enhance the eyes ability to visually adapt to different light environments, and protect the health of the eye and retina.